Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)

Update Il y a 5 ans
Reference: NCT01146262

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -


Dendritic cells vaccinations are increasingly used in order to develop antitumoral immune response. This will be a Phase 2 trial using autologous dendritic cells pulsed with leukemic apoptotic corpse in acute myelogenous leukemia (AML) patients in first or second Complete remission (CR).

Inclusion criteria

  • Acute myelogenous leukemia